Buntanetap (L-Tartrate)
Product Specifications
UNSPSC Description
Buntanetap (L-Tartrate) is an orally administered small molecule inhibitor of several neurotoxic proteins. Buntanetap reduces amyloid precursor protein (APP) production by blocking its mRNA translation[1].
Target Antigen
Amyloid-β
Type
Reference compound
Related Pathways
Neuronal Signaling
Applications
Neuroscience-Neurodegeneration
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/buntanetap-l-tartrate.html
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
CN1[C@@](N(C)CC2)([H])[C@@]2(C)C3=C1C=CC(OC(NC4=CC=CC=C4)=O)=C3.OC([C@H](O)[C@@H](O)C(O)=O)=O
Molecular Weight
487.50
References & Citations
[1]Gubar M , et al. Buntanetap: Breakthrough in Treatment of Alzheimer's and Parkinson's. BioPharma Media. 2023, 11.
Shipping Conditions
Room Temperature
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-16009B/Buntanetap-L-Tartrate-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-16009B/Buntanetap-L-Tartrate-SDS-MedChemExpress.pdf
Clinical Information
No Development Reported
CAS Number
865795-23-9
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
